期刊文献+

Recent progress in Helicobacter pylori treatment 被引量:23

原文传递
导出
摘要 The main challenge in the field of Helicobacter pylori(H.pylori)infection is antibiotic resistance,which influences the efficacy of eradication regimens.Bismuth-containing quadruple therapy has been confirmed as an effective regimen for eradicating H.pylori,especially in strains with antibiotic resistance.High-dose proton-pump inhibitor-amoxicillin dual therapy could decrease the use of unnecessary antibiotics,which is a promising alternative approach.Adjuvant therapy(specific probiotic or vitamin)also showed good results,although more evidence is needed.Novel anti-H.pylori drugs are needed,and the establishment of the H.pylori database is an effective way to acknowledge the real-time information of H.pylori management.This review provides the recent progress of H.pylori treatment,and further studies are needed to address the role of different regimens in improving H.pylori eradication rate,especially in strains with antibiotics resistance.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2020年第3期335-343,共9页 中华医学杂志(英文版)
基金 This work was supported by grants from the National Natural Science Foundation of China(Nos.81460116,81470832,81670507,and 81870395) the Graduate Innovation Fund of Jiangxi Province(No.YC2016-B025).
  • 相关文献

参考文献1

二级参考文献20

  • 1MANTEL N,HAENSZEL W.Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the National Cancer Institute . 1959
  • 2David Y. Graham,Yi-Chia Lee,Ming-Shiang Wu.Rational Helicobacter pylori therapy: evidence based medicine rather than medicine based evidence[J].Clinical Gastroenterology and Hepatology.2013
  • 3Jyh-Ming Liou,Chieh-Chang Chen,Mei-Jyh Chen,Chien-Chuan Chen,Chi-Yang Chang,Yu-Jen Fang,Ji–Yuh Lee,Shih-Jer Hsu,Jiing-Chyuan Luo,Wen-Hsiung Chang,Yao-Chun Hsu,Cheng-Hao Tseng,Ping-Huei Tseng,Hsiu-Po Wang,Ueng-Cheng Yang,Chia-Tung Shun,Jaw-Town Lin,Yi-Chia Lee,Ming-Shiang Wu.Sequential versus triple therapy for the first-line treatment of Helicobacter pylori : a multicentre, open-label, randomised trial[J].The Lancet.2012
  • 4Malfertheiner Peter,Megraud Francis,O’Morain Colm A,Atherton John,Axon Anthony T R,Bazzoli Franco,Gensini Gian Franco,Gisbert Javier P,Graham David Y,Rokkas Theodore,El-Omar Emad M,Kuipers Ernst J.Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report[].Gut.2012
  • 5Essa Abdallah Said,Kramer Jennifer Rosenthal,Graham David Y,Treiber Gerhard.Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing "concomitant therapy" versus triple therapy for Helicobacter pylori eradication[].Helicobacter.2009
  • 6Angelo Zullo,Giuseppe Scaccianoce,Vincenzo De Francesco,Valentina Ruggiero,Pasquale D’Ambrosio,Luigi Castorini,Leonilde Bonfrate,Lucy Vannella,Cesare Hassan,Piero Portincasa.Concomitant, sequential, and hybrid therapy for H. pylori eradication: a pilot study.[J].Clinics and Research in Hepatology and Gastroenterology.2013
  • 7Hossein Sardarian,Hafez Fakheri,Vahid Hosseini,Tarang Taghvaei,Iradj Maleki,Marjan Mokhtare.Comparison of Hybrid and Sequential Therapies for H elicobacter pylori Eradication in I ran: A Prospective Randomized Trial[J].Helicobacter.2012(2)
  • 8Deng–Chyang Wu,Ping–I. Hsu,Jeng–Yih Wu,Antone R. Opekun,Chao–Hung Kuo,I.–Chen Wu,Sophie S.W. Wang,Angela Chen,Wen–Chun Hung,David Y. Graham.Sequential and Concomitant Therapy With Four Drugs Is Equally Effective for Eradication of H pylori Infection[J].Clinical Gastroenterology and Hepatology.2010(1)
  • 9Luigi Gatta,Nimish Vakil,Dino Vaira,Carmelo Scarpignato.Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy[J]. BMJ . 2013 (aug0)
  • 10William D Chey,Benjamin CY Wong.American College of Gastroenterology Guideline on the Management of Helicobacter pylori Infection. The American journal of Gastroenterology . 2007

共引文献7

同被引文献200

引证文献23

二级引证文献198

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部